Saturday, May 31, 2025

Latest

Medmen One Step Closer to Closing PharmaCann Merger

Medmen Enterprises (CSE: MMEN) announced that it is one step closer to closing its acquisition of PharmaCann LLC this morning. The waiting period has expired under whats known as the “HSR Act”, which is an antitrust act intended to prevent anti-competitive mergers and acquisitions. The firm was initially hit with whats known as a “second request” for more information on March 15, 2019.

As a result of the expiration, it verifies that the Department of Justice is not looking for additional information, and that the two firms can continue with the proposed merger. Medmen initially announced that both they and PharmaCann had submitted the required information on August 9, 2019.

The merger, which entered definitive agreement on December 24, 2018, is expected to now close by the end of the calendar year. It will bring together two firms with sizable footprints across the United States, with the combined firm having 92 licenses to open retail cannabis locations of which 38 are currently operational today across 12 states.

While the closing of the agreement has been a long time coming for Medmen shareholders, the merger provides an example for the rest of the cannabis sector of what a second request from the Department of Justice can mean operationally. While the firm never specifically gave a date for the intended closing of the arrangement, it has been close to six months since the initial second request was placed by the DOJ, which undoubtedly prolonged the waiting period before the closing of the arrangement. Notably, the Cresco Labs (CSE: CL) and Origin House (CSE: OH) proposed merger was hit with a second request on June 10, 2019. A similar delay would result in that deal not closing until the new year effectively.

Medmen Enterprises closed yesterdays session at $2.65.


Information for this briefing was found via Sedar and MedMen Enterprises. The author has no affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

How To Profit From $3300 Gold? An Inside Look At A Massive 300,000 Oz Project | Martino De Ciccio

We’re At The Start of a Great Silver Boom | Ross McElroy & Andy Bowering – Apollo Silver Corp

Equinox Gold Q1 Earnings: When Everything Goes Wrong

Recommended

ESGold Begins Concentration Tests Ahead Of First Production

Sterling Metals Hits 0.21% Copper Over 482.8 Metres In First Drilling At Soo Copper project

Related News

MedMen Reports Pro-Forma Preliminary Revenue of US$61.3M for Fourth Quarter

MedMen Enterprises (CSE: MMEN) released preliminary financials for the fourth quarter of FY2019, stating system-wide...

Tuesday, August 13, 2019, 10:31:36 AM

Medmen Posts Revenues of $43.9 Million, Net Loss of $82.6 Million For First Quarter

Medmen Enterprises (CSE: MMEN) filed its first quarter 2020 financials these evening, revealing revenues of...

Tuesday, November 26, 2019, 05:02:41 PM

Medmen Modifies Debt Facilities, Lease Terms To Improve Near Term Liquidity

MedMen Enterprises (CSE: MMEN) this morning announced that it has amended several of its outstanding...

Friday, July 3, 2020, 08:36:27 AM

Is the End of the Line Near for MedMen?

It’s long been known by cannabis industry followers that MedMen Enterprises (CSE: MMEN) has a...

Tuesday, June 11, 2019, 07:30:12 AM

MedMen Secures Further Funding From Gotham Green Partners

MedMen Enterprises Inc. (CSE:MMEN) has returned to the trough with Gotham Green Partners as expected,...

Wednesday, July 10, 2019, 10:44:27 AM